Abstract 207: Performance Of The Universal Tor Rule For Out-of-hospital Cardiac Arrest Cases Not Witnessed By Ems Providers In The Pan Asian Resuscitation Outcomes Study

Abstract

Introduction: In order to make effective use of limited medical resources in an aging society, ILCOR emphasizes the importance of considering the Termination of Resuscitation (TOR) rule in the prehospital setting. In Europe and the United States, the Universal TOR rule (no prehospital cardiac resumption, no witnessed by EMS, no shock at the scene) is utilized in the field. We used the Pan-Asian Resuscitation Outcomes (PAROS) data to examine cases of out-of-hospital cardiac arrest not witnessed by EMS providers in Singapore, Japan, Korea, and Taiwan. We also examined the validity of Universal TOR rule. Methods: This was a retrospective cohort study examining data from January 1, 2009 to June 31, 2018 of the Pan Asian Resuscitation Outcomes Study. We included patients with OHCA who were non-traumatic cardiac arrest and not witnessed by EMS providers. We examined the background of the patients, activities and response times of EMS, and survival outcomes. Then, we calculated the specificity, positive predictive value, etc. of cases that met the Universal TOR rule for poor neurological outcomes (CPC ≥ 3) . Results: The breakdown of cases was as follows: Singapore (10,976)/ Japan (117,814)/ Korea (17,926)/ Taiwan (17,063). Of these, Singapore 440 (4.0%)/ Japan 6,845 (5.8%)/ Korea 1,522 (8.5%)/ Taiwan 1,190 (7.0%) were discharged alive, and Singapore 263 (2.4%)/ Japan 3,791 (3.2%)/ Korea 679 (3.8%)/ Taiwan 457 (2.7%) were discharged alive for CPC 1 and 2. For CPC≥3 cases, the specificity of the universal TOR rule was Singapore 0.970/ Japan 0.912/ Korea 0.887/ Taiwan 0.742, and the positive predictive value was Singapore 0.999/ Japan 0.997/ Korea 0.995/ Taiwan 0.992. Conclusions: The positive predictive value for poor neurological prognosis at 1 month, among Universal TOR rule-compliant cases in the four countries was more than 99%. However, there were differences in the specificity of poor neurological outcome between countries.